全文获取类型
收费全文 | 9709篇 |
免费 | 617篇 |
国内免费 | 40篇 |
专业分类
耳鼻咽喉 | 128篇 |
儿科学 | 789篇 |
妇产科学 | 386篇 |
基础医学 | 968篇 |
口腔科学 | 180篇 |
临床医学 | 616篇 |
内科学 | 1826篇 |
皮肤病学 | 253篇 |
神经病学 | 335篇 |
特种医学 | 328篇 |
外科学 | 1910篇 |
综合类 | 349篇 |
现状与发展 | 30篇 |
一般理论 | 2篇 |
预防医学 | 381篇 |
眼科学 | 580篇 |
药学 | 464篇 |
中国医学 | 24篇 |
肿瘤学 | 817篇 |
出版年
2023年 | 241篇 |
2022年 | 157篇 |
2021年 | 282篇 |
2020年 | 186篇 |
2019年 | 206篇 |
2018年 | 318篇 |
2017年 | 229篇 |
2016年 | 274篇 |
2015年 | 263篇 |
2014年 | 387篇 |
2013年 | 416篇 |
2012年 | 544篇 |
2011年 | 565篇 |
2010年 | 420篇 |
2009年 | 343篇 |
2008年 | 464篇 |
2007年 | 522篇 |
2006年 | 458篇 |
2005年 | 375篇 |
2004年 | 297篇 |
2003年 | 298篇 |
2002年 | 259篇 |
2001年 | 229篇 |
2000年 | 230篇 |
1999年 | 219篇 |
1998年 | 122篇 |
1997年 | 105篇 |
1996年 | 86篇 |
1995年 | 76篇 |
1994年 | 62篇 |
1993年 | 68篇 |
1992年 | 101篇 |
1991年 | 102篇 |
1990年 | 80篇 |
1989年 | 91篇 |
1988年 | 91篇 |
1987年 | 88篇 |
1986年 | 84篇 |
1985年 | 115篇 |
1984年 | 59篇 |
1983年 | 59篇 |
1982年 | 47篇 |
1980年 | 46篇 |
1979年 | 81篇 |
1978年 | 50篇 |
1977年 | 50篇 |
1976年 | 52篇 |
1974年 | 45篇 |
1973年 | 48篇 |
1972年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
The meta-analysis was performed to assess the efficacy and safety of daily oral L-arginine and phosphodiesterase type 5 inhibitors (PDE5Is) alone or combination in treating patients with erectile dysfunction (ED). We performed a search of randomised controlled trials in the following databases: PubMed, EMBASE and Cochrane Library databases. Four articles including 373 patients were studied. Erectile functions were significantly improved in three therapy groups compared with baseline. Patients who received the combination of L-arginine and PDE5Is showed significant improvement compared to those treated with L-arginine and PDE5Is alone, as assessed by sexual function index (p <0.00001 and p =0.005, respectively) and total testosterone (p <0.00001 and p =0.0007, respectively). Furthermore, patients who treated with PDE5Is alone exhibited the better efficacy than those treated with L-arginine alone in respects of sexual function index (p <0.00001) and total testosterone (p =0.0001). However, the combination of L-arginine and PDE5Is had no obvious difference relative to PDE5Is alone in terms of various adverse events (AEs). Conclusively, compared with monotherapy, the combination of L-arginine and PDE5Is showed a greater improvement of sexual function and total testosterone, and did not significantly increase the AEs. Besides, PDE5Is alone revealed a better effect than those treated with L-arginine alone for patients with ED. 相似文献
62.
Infertility is a major health issue affecting over 48.5 million couples around the world, with the male factor accounting for about 50% of the cases. The conventional semen analysis recommended by the World Health Organization (WHO) is the cornerstone in the evaluation of male fertility status. It includes macroscopic and microscopic evaluation of the ejaculate, which reflects the production of spermatozoa in the testes, the patency of the duct system and the glandular secretory activity. Evaluation of seminal fructose, sperm vitality and leucocytes (Endtz test) are useful adjuncts to semen analysis that provide information on specific clinical conditions. Though several computer-assisted sperm analysis (CASA) systems have been developed, conventional methods for semen analysis are still widely accepted in clinical practice. This review summarises the conventional techniques used in routine semen analysis and their diagnostic value in clinical andrology. 相似文献
63.
Varicocele is one of the major causes of male infertility and has a negative impact on spermatogenesis. The conventional semen analysis does not reveal the underlying subcellular mechanisms associated with defects in spermatozoa. Proteomics and bioinformatics analysis can be used to identify the molecular aetiologies associated with poor semen quality in varicocele patients. Mitochondrial dysfunction has been identified as the main factor affecting normal physiological functions of spermatozoa. This article discusses the proteomic studies of spermatozoa and seminal plasma in varicocele patients. Proteomics can identify potential spermatozoa and seminal plasma biomarkers in varicocele-mediated male infertility. In future, these protein biomarkers can be useful in the development of noninvasive diagnostic and therapeutic strategies for varicocele patients. 相似文献
64.
Haitham Elbardisi Ahmad Majzoub Christiana Daniel Fadwa Al.Ali Mohamed Elesnawi Kareim Khalafalla Ashok Agarwal Ralf Henkel Alia Alattar Ibrahim Al-Emadi Mohamed Arafa 《Andrologia》2021,53(8):e14135
In this study, we investigated the prevalence of sexual dysfunction among males with advanced chronic kidney disease and the effect of treating hyperprolactinemia among these patients. In this prospective study, patients were assessed with history, physical examination, hormonal assessment, and two questionnaires, IIEF and AIPE. Patients with hyperprolactinemia received treatment with cabergoline 0.5 mg once per week for 6 months and were re-evaluated. A total of 102 patients were included in this study, 75 (73.53%) were on hemodialysis, 13 (12.75%) on peritoneal dialysis and 14 (13.73%) on medical treatment alone. Ninety (88.24%) patients had premature ejaculation, 85 (83.33%) had anything from mild-to-moderate-to-severe erectile dysfunction. The incidence of hypogonadism and hyperprolactinemia was 34.4%. Patients treated with cabergoline (n = 26) showed a significant increase in LH levels (p = .003) and a significant decrease in prolactin levels (p = .003). Testosterone levels and the incidence of erectile dysfunction or premature ejaculation did not improve significantly. There is a high incidence of sexual dysfunction among patients. Treatment of hyperprolactinemia is effective in correcting prolactin levels, but does not improve erectile dysfunction or premature ejaculation. Therefore, treating hyperprolactinemia is not an overall effective treatment for erectile dysfunction in these patients. 相似文献
65.
G. Erdoes A. Koster E. Ortmann M. I. Meesters D. Bolliger E. Baryshnikova B. Martinez Lopez De Arroyabe A. Ahmed M. D. Lance M. Ranucci C. von Heymann S. Agarwal H. B. Ravn 《Anaesthesia》2021,76(3):381-392
Modern four-factor prothrombin complex concentrate was designed originally for rapid targeted replacement of the coagulation factors II, VII, IX and X. Dosing strategies for the approved indication of vitamin K antagonist-related bleeding vary greatly. They include INR and bodyweight-related protocols as well as fixed dose regimens. Particularly in the massively bleeding trauma and cardiac surgery patient, four-factor prothrombin complex concentrate is used increasingly for haemostatic resuscitation. Members of the Transfusion and Haemostasis Subcommittee of the European Association of Cardiothoracic Anaesthesiology performed a systematic literature review on four-factor prothrombin complex concentrate. The available evidence has been summarised for dosing, efficacy, drug safety and monitoring strategies in different scenarios. Whereas there is evidence for the efficacy of four-factor prothrombin concentrate for a variety of bleeding scenarios, convincing safety data are clearly missing. In the massively bleeding patient with coagulopathy, our group recommends the administration of an initial bolus of 25 IU.kg-1. This applies for: the acute reversal of vitamin K antagonist therapy; haemostatic resuscitation, particularly in trauma; and the reversal of direct oral anticoagulants when no specific antidote is available. In patients with a high risk for thromboembolic complications, e.g. cardiac surgery, the administration of an initial half-dose bolus (12.5 IU.kg-1) should be considered. A second bolus may be indicated if coagulopathy and microvascular bleeding persists and other reasons for bleeding are largely ruled out. Tissue-factor-activated, factor VII-dependent and heparin insensitive point-of-care tests may be used for peri-operative monitoring and guiding of prothrombin complex concentrate therapy. 相似文献
66.
67.
Jue Chen MD PhD Lei Guo MM Lian Gu MPsy Hui Han MPsy 《The International journal of eating disorders》2021,54(1):102-106
In the past 40 years, the prevalence of eating disorders (ED) in China has shown an increasing trend, leading to an urgent need to develop efficient treatment modes and methods. Since the beginning of the new century, the diagnosis, treatment, and research of ED in China have been under development. This article gives an introduction and commentary on the treatment modes, treatment methods and their applications in ED in China. There are two main treatment forms for ED until now, that is, inpatient treatment and outpatient treatment. Inpatient treatment is recommended as the first choice. Since 2008, clinical psychotherapies such as cognitive behavioral therapy (CBT), dialectical behavioral therapy (DBT), and family-based treatment (FBT), which are effective for pathological symptoms of ED, have been introduced into China and developed clinically. Group CBT and group DBT for patients with ED and group FBT for caregivers might be the most efficient psychotherapy in China nowadays. A multi-family FBT support group could be developed as the basic treatment of ED patients. Although these new types of psychotherapy have observed effectiveness in clinical application, the Randomized Controlled Trials (RCT) are rare and need to be developed. 相似文献
68.
Agarwal V Gupta B Singhal U Bajpai SK 《Indian journal of physiology and pharmacology》1997,41(4):404-408
Serum cholesterol, triglycerides and total lipids were estimated in twelve students exposed to varying degree of examination stress. Serum cholesterol and triglycerides exhibited a rise proportional to degree of examination stress whereas total lipids exhibited an initial rise followed by a fall. Values of all these parameters attained control level when the stress was over. The rise in serum cholesterol and triglycerides seems to be due to stress induced changes in hormonal levels and peripheral lipolysis respectively. 相似文献
69.
M. K. Agarwal S. P. Rai R. M. Gupta 《Indian journal of otolaryngology and head and neck surgery》1994,46(2):78-82
The present study was carried out on 75 patients suffering from chronic otitis media and 25 healthy age and sex matched controls. The T. rosette percentage were depressed in malnouirished immunity (CMI), but once malnutrition was treated the CMI was improved. Anergy to challenge does of 2 : 4 DNCB was not observed in any groups. Weak response was observed in 4% of controls, 18.7% of chronic otitis media patients and 5.7% of post treatment cases. Serum IgG, IgA and IgM levels were elevated in chronic otitis media patients from controls but once the infections were eliminated by treatment their values became insignificant (p 0.05) from controls. Presence of Malnutrition significantly contributed to suppression of CMI response but no suppression of humoral immunity was observed. 相似文献
70.